These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6967359)

  • 1. Partial characterization of a prostaglandin-induced suppressor factor.
    Rogers TJ; Nowowiejski I; Webb DR
    Cell Immunol; 1980 Mar; 50(1):82-93. PubMed ID: 6967359
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced clonability of human T lymphocytes caused by their culturing in vitro.
    Górski A; Gaciong Z; Dupont B
    Immunology; 1981 Nov; 44(3):617-22. PubMed ID: 6976309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical identification of a prostaglandin-induced T suppressor (PITS).
    Webb DR; Wieder KJ; Rogers TJ; Healy CT; Nowowiejski-Wieder I
    Lymphokine Res; 1985; 4(2):139-49. PubMed ID: 2987625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 rather than lymphocyte-activating factor produced by activated human mononuclear cells stimulates increases in murine thymocyte cAMP.
    Oppenheim JJ; Koopman WJ; Wahl LM; Dougherty SF
    Cell Immunol; 1980 Jan; 49(1):64-73. PubMed ID: 6243256
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin E1 treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses.
    Krakauer KA; Torrey SB; Zurier RB
    Clin Immunol Immunopathol; 1978 Nov; 11(3):256-66. PubMed ID: 309371
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice.
    Suzuki S; Huchet R
    Cell Immunol; 1982 Apr; 68(2):349-58. PubMed ID: 6124318
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of tumour-promoting agents with immunofunctional cells in vitro and in vivo.
    Baxter CS; Schoof RA; Lawrence AT
    IARC Sci Publ; 1984; (56):305-17. PubMed ID: 6336085
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice.
    Kelley VE; Winkelstein A; Izui S; Dixon FJ
    Clin Immunol Immunopathol; 1981 Nov; 21(2):190-203. PubMed ID: 7028332
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation of human T cell subsets.
    Gualde N; Goodwin JS
    Cell Immunol; 1982 Jul; 70(2):373-9. PubMed ID: 6215130
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens.
    Novogrodsky A; Rubin AL; Stenzel KH
    J Immunol; 1979 Jan; 122(1):1-7. PubMed ID: 216745
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP.
    Kierszenbaum F; Waksman BH
    Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885
    [No Abstract]   [Full Text] [Related]  

  • 13. Endorphin peptides enhance mitogen-induced T cell proliferation which has been suppressed by prostaglandins.
    Hemmick LM; Bidlack JM
    Adv Exp Med Biol; 1991; 288():211-4. PubMed ID: 1950732
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
    Walker C; Kristensen F; Bettens F; deWeck AL
    J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.
    Lauro GM; Di Lorenzo N; Grossi M; Maleci A; Guidetti B
    Acta Neuropathol; 1986; 69(3-4):278-82. PubMed ID: 3485879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a product from Salmonella typhimurium with the ability to inhibit mitogen-induced proliferation of murine splenic T-lymphocytes.
    Matsui K
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):155-60. PubMed ID: 8731024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of suppressor cell activation via endogenous prostaglandin synthesis: the role of T cells and macrophages.
    Webb DR; Nowowiejski I
    Cell Immunol; 1981 Sep; 63(2):321-8. PubMed ID: 6456077
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphine enhancement of mitogen-induced T-cell proliferation.
    Bidlack JM; Hemmick LM
    Prog Clin Biol Res; 1990; 328():405-8. PubMed ID: 2137628
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
    Goodwin JS; Messner RP; Peake GT
    J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tri-iodothyronine on the phytohaemagglutinin response of T lymphocytes.
    Keast D; Taylor K
    Clin Exp Immunol; 1982 Jan; 47(1):217-20. PubMed ID: 6980069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.